Moreover, Bussard et al., have also suggested a role for TGFβ in converting bone marrow-derived endothelial cells into CAFs [111], however additional work is necessary to determine if this process occurs in prostate cancer. This evidence concerns the gene TGFB1 and prostate carcinoma.